According to the National Comprehensive Cancer Network, more than 60% of women with a pathogenic germline mutation in BRCA1 or BRCA2 are projected to develop breast cancer over the course of their lifetime [4]. This evidence concerns the gene BRCA2 and breast carcinoma.